Ryan Kole
Algemeen Directeur bij Beyond Barriers Therapeutics, Inc.
Actieve functies van Ryan Kole
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Vcapital, Inc.
 Vcapital, Inc. Investment ManagersFinance Vcapital Inc (Vcapital) is a venture capital firm founded in 2000 by Len A Batterson and James Vaughan. The firm is headquartered in Chicago, Illinois. | Private Equity Investor | 01-01-2016 | - |
Beyond Barriers Therapeutics, Inc.
 Beyond Barriers Therapeutics, Inc. BiotechnologyHealth Technology Beyond Barriers Therapeutics, Inc. is an American company that is developing a novel product to treat inflammation and cell death following traumatic brain injury (TBI). The company is based in Illinois, and the CEO of the company is Ryan Kole. The company aims to decrease the harmful effects of TBI by providing active therapy that could be administered intranasally immediately after impact to the head. The company's proprietary technology will lay the foundation for use of a novel, more effective delivery mechanism of small molecules to the brain. | Algemeen Directeur | - | - |
Loopbaan van Ryan Kole
Opleiding van Ryan Kole
| The University of Chicago | Masters Business Admin |
| University of Illinois At Urbana–Champaign | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
Operationeel
| Private Equity Investor | 1 |
| Undergraduate Degree | 1 |
| Masters Business Admin | 1 |
Sectoraal
| Consumer Services | 3 |
| Finance | 2 |
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Vcapital, Inc.
Vcapital, Inc. Investment ManagersFinance Vcapital Inc (Vcapital) is a venture capital firm founded in 2000 by Len A Batterson and James Vaughan. The firm is headquartered in Chicago, Illinois. | Finance |
Beyond Barriers Therapeutics, Inc.
Beyond Barriers Therapeutics, Inc. BiotechnologyHealth Technology Beyond Barriers Therapeutics, Inc. is an American company that is developing a novel product to treat inflammation and cell death following traumatic brain injury (TBI). The company is based in Illinois, and the CEO of the company is Ryan Kole. The company aims to decrease the harmful effects of TBI by providing active therapy that could be administered intranasally immediately after impact to the head. The company's proprietary technology will lay the foundation for use of a novel, more effective delivery mechanism of small molecules to the brain. | Health Technology |
